JohnkhoffAR, HuijgensPC, SchreuderWO, TeuleGJJ, HeimansJJ. Hypophyseal non-Hodgkin's lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy.J Neurooncol1993; 17: 155–8.
4.
SamuelsMA, De La MonteS.A 49 vear-old-man with hypopituitarism, multifocal neurological defects and an intracranial massN Engl J Med1994; 331: 861–8.
5.
FineHA, MayerRJ. Primary central nervous system lymphoma.Ann Intern Med1993; 119: 1093–104.
6.
LundbergPO, OstermanPO, WideL.Serum prolactin in patients with hypothalamus and pituitary disorders.J Neurosurg1981; 55: 194–9.
7.
RossRJM, GrossmanA, BoulouxP, ReesLH, DoniachI, BesserGM. The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas.Clin Endocrinol1985; 23: 227–35.
8.
BevanJS, BurkeCW, EsiriDM, AdamsCBT. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargementAm J Med1987; 82: 29–32.
9.
RillemaJA, LawsonDM. Identification of two specific prolactin binding sites on Nb2 rat lymphoma cells.Proc Soc Exp Biol Med1994; 205: 75–9.
10.
PellegriniI, LebrunJJ, AliS, KellyPA. Expression of prolactin and its receptor in human lymphoid cells.Mol Endocrinol1992; 6: 1023–31.
11.
GellersenB, BonhoffA, HuntN, BohnetHG. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion.Endocrinology1989; 125: 2853–61.
12.
GrobeN, RuhleH, EckelmannG.Hyperprolactinaemia in malignant lymphomas.Dt Med Wochenschr1990; 115: 1825–7.